Discontinuing MS treatment During Pregnancy: What Happens Next

Natalizumab is specially prescribed to those people who have for multiple sclerosis (MS) while being pregnant. When people having multiple sclerosis respond to none other drugs they are prescribed Natalizumab, but two studies of late have accentuated the effects of discontinuing the powerful and newer natalizumab which could have potential side effects, of course fatal in nature. The researchers have explored that women who are bent on having natalizumab would be experiencing bigger disease activities when they are discontinuing drug intake before pregnancy, now the risk would lower if they do so before conception. This study report came out in the online journal of American Academy, Neurology on February 7, 2018. However, the second study says that natalizumab when taken during the first trimester it may cause miscarriage.

The previous research report however confirmed that MS is not at all linked with birth defects and pregnancy also has no impact upon the disease process as well as the older medications projected to be comparatively safer an alternative to be taken during pregnancy. However, no research so far has been conducted on the impact of natalizumab. Those who are not pregnant have shown that right after stopping the drug there could be an increase in disease activity.

As according to the author Emilio Murtaccio who is the Pedro Zenocchi Foundation MD based in Florence, Italy, women who are having MS may face difficulty in conceiving as the woman and her physician should be weighing down the risks as against the advantages of medications that regulate MS disease activity. They have chosen to carry out two studies to inspect the dangers of natalizumab in mother as well as child, in that way the woman would be reaching more well informed decision regarding pregnancy. To conduct both the studies, researchers have tracked 92 pregnant women among 83 were taking natalizumab for declining and remitting MS. Initially they were rifted into two groups one who used to take natalizumab prior to their last menstrual period another who took it right after last period. Such trial was compared with another group who either avoided taking the medicine or took interferon betas.

Natalizumab posed risks for both babies as well as pregnant women alike and the probability of miscarriage is higher than normal circumstance. Women who were bent on taking interferon betas or nothing for MS are having lesser risks for their unborn babies. Researchers are looking for birth defects for those thriving on Natalizumab but not much conclusive research has been performed. As for Portaccio women on natalizumab, if they want to become pregnant it would be better to stop consuming the drug at an immediate basis. However if there is a risk of heightened disease activity, such course would be lowering down the danger.

However considering the limitations, studies show that women who were charged with natalizumab would certainly be differing from those who were not treated with that specific drug, however there are fewer ways which were not integrated into the study also the relapse severity was not integrated as well.

Women's Health Info